Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Method for treating hyperglycemia
Active metal fuel cells
Synergistic compositions for the treatment of topical viral infections
Active pulse blood constituent monitoring
MEMS structure and method for making the same
Washing machine
Stereoscopic editing for video production, post-production and display adaptation
  Randomly Featured Patents
Nuclear reactor fuel assembly end fitting
Sleeping bag with replaceable air mattress
Method and for system for detecting damaged bills
Production of 1-.beta.-D-ribofuranosyl-1,2,4-triazole
Replaceable bit screwdriver assembly
Apparatus and method for polishing end-surface of ferrule
Coin assorter and coin inputting device
Paper dispenser
Milk sucking pump
Method and apparatus for controlling root growth